ClinicalTrials.Veeva

Menu

Education to Improve Pneumococcal Vaccine Uptake Among Older Adults (PROPEL)

University of Ottawa logo

University of Ottawa

Status

Not yet enrolling

Conditions

Pneumococcal Vaccine Knowledge
Pneumococcal Vaccine Attitude
Pneumococcal Vaccine Uptake
Vaccination Willingness

Treatments

Other: Web-based educational video on pneumococcal vaccination
Other: Reminder email to be vaccinated

Study type

Interventional

Funder types

Other

Identifiers

NCT06234683
CIRN Project SH-34

Details and patient eligibility

About

The goal of this trial is to compare the effect of a web-based educational video about pneumococcal vaccines and a reminder email to get vaccinated (intervention) with a reminder email alone (comparator) in adults aged 65 or older living in any Canadian province who reported not having received a pneumococcal vaccine.

The main questions this trial aims to answer are:

  1. does the educational intervention improve pneumococcal vaccine uptake,
  2. does the educational intervention improve willingness to be vaccinated,
  3. does the educational intervention improve knowledge of pneumococcal vaccination,
  4. and does the educational intervention improve attitudes towards pneumococcal vaccines/vaccination?

Eligible participants who provide electronic consent will:

  1. fill out a web-based baseline survey,
  2. receive access to the educational video (if assigned to the intervention group),
  3. receive an email reminder to be vaccinated (both groups),
  4. and fill in a web-based follow-up survey.

Full description

This research project is a web-based randomized controlled trial (RCT), targeting adults aged 65 years and older across all Canadian provinces. The primary objectives of this study are twofold. Firstly, it aims to assess the participants' knowledge, barriers, facilitators, and willingness to receive the pneumococcal vaccine at baseline. Secondly, it aims to evaluate the impact of a video-led educational intervention on pneumococcal vaccine literacy, willingness to be vaccinated, and the actual uptake of the vaccine. To this end, participants will be recruited through various online channels. Only individuals who have not received the pneumococcal vaccine will be considered eligible for inclusion. For the second objective, participants will be randomly assigned to either the intervention group (short video on pneumococcal vaccination) or the control group (reminder to receive a pneumococcal vaccine). Consenting participants will be required to complete two surveys: one at baseline and another approximately six months post-intervention. These surveys will provide valuable data for analyzing the effectiveness of the educational intervention in improving participants' knowledge, willingness to be vaccinated, and the actual uptake of the pneumococcal vaccine. Findings from this research will contribute to the understanding of factors influencing pneumococcal vaccine decision-making among older adults, ultimately informing strategies to enhance vaccine uptake and public health outcomes in this population.

Enrollment

786 estimated patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  1. adults aged ≥ 65 residing in any Canadian province,
  2. community dwelling (i.e., living outside of nursing homes),
  3. reporting not having received a pneumococcal vaccine, and
  4. being able to understand English and/or French.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

786 participants in 2 patient groups, including a placebo group

Web-based educational video on pneumococcal vaccination and reminder email to be vaccinated
Active Comparator group
Treatment:
Other: Reminder email to be vaccinated
Other: Web-based educational video on pneumococcal vaccination
Reminder email to be vaccinated
Placebo Comparator group
Treatment:
Other: Reminder email to be vaccinated

Trial contacts and locations

1

Loading...

Central trial contact

Cassandra Laurie, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems